INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Edit Your Profile

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER Journal

publication venue for

Long-term outcomes following a diagnosis of ovarian cancer at the time of preventive oophorectomy among BRCA1 and BRCA2 mutation carriers. 30:825-830. 2020
Correlation of differential ascites volume with primary cytoreductive surgery outcome, lymph node involvement, and disease recurrence in advanced ovarian cancer. 29:922-928. 2019
Examining Survival Outcomes of 852 Women With Advanced Ovarian Cancer: A Multi-institutional Cohort Study. 28:925-931. 2018
A Comparison of Survival Outcomes in Advanced Serous Ovarian Cancer Patients Treated With Primary Debulking Surgery Versus Neoadjuvant Chemotherapy. 27:668-674. 2017
An Organizational Guideline for Gynecologic Oncology Services. 25:551-558. 2015
Risk Factors for Ovarian Cancers With and Without Microsatellite Instability. 24:664-669. 2014
Risk Factors for Ovarian Cancers With and Without Microsatellite Instability (Retracted Article). 23:1010-1015. 2013
Surgical Outcome of Robotic Surgery in Morbidly Obese Patient With Endometrial Cancer Compared to Laparotomy. 22:76-81. 2012
Protocol Development for Ovarian Cancer Treatment in Kenya A Brief Report. 21:424-427. 2011
Teaching Cervical Cancer Surgery in Low- or Middle-Resource Countries. 20:1604-1608. 2010
Randomized Phase III Study of Canfosfamide in Combination With Pegylated Liposomal Doxorubicin Compared With Pegylated Liposomal Doxorubicin Alone in Platinum-Resistant Ovarian Cancer. 20:772-780. 2010
The Fallopian Tube: Primary Site of Most Pelvic High-grade Serous Carcinomas. 19:58-64. 2009
The impact of obesity on surgery in gynecological oncology: A review. 16:944-952. 2006
A retrospective analysis of neoadjuvant platinum-based chemotherapy versus up-front surgery in advanced ovarian cancer. 16:47-53. 2006
A retrospective analysis of neoadjuvant platinum-based chemotherapy versus up-front surgery in advanced ovarian cancer. 16:47-53. 2006
Uterine papillary serous carcinoma: evaluation of multimodality treatment with abdominopelvic radiotherapy and chemotherapy. 16:278-285. 2006
Uterine papillary serous carcinoma: evaluation. of multimodality treatment with abdominopelvic radiotherapy and chemotherapy. 16:278-285. 2006
OPTIMAL SURGICAL CYTOREDUCTION IN PATIENTS WITH STAGE III AND STAGE IV ENDOMETRIAL CARCINOMA: A STUDY OF SURVIVAL AND MORBIDITY. 13:28.2-2828. 2003
Use of CA-125 and ultrasound in high-risk women. 12:86-91. 2002
Evaluation of the Pfannenstiel incision for radical abdominal hysterectomy with pelvic and para-aortic lymphadenectomy. 9:418-420. 1999
Radical hysterectomy for cervical cancer: Hysterectomy before pelvic lymphadenectomy or vice versa?. 9:307-311. 1999
Use of CA-125 and ultrasound in high-risk women. 12:86-91.
Vulvar intra-epithelial neoplasia-treatment outcome. 6:145-148.
THE IMPACTS OF NEOADJUVANT CHEMOTHERAPY AND OF CYTOREDUCTIVE SURGERY ON TEN-YEAR SURVIVAL FROM ADVANCED OVARIAN CANCER 2020
Urinary diversion after exenterative surgery: continent conduit remains my ideal approach 2021
Erratum: Risk factors for ovarian cancers with and without microsatellite instability (International Journal of Gynecological Cancer (2013) 23 (1010-1015)) 2014

category

OBSTETRICS & GYNECOLOGY Category
ONCOLOGY Category

International Standard Serial Number (ISSN)

1048-891X

Electronic International Standard Serial Number (EISSN)

1525-1438

journal abbreviation

INT J GYNECOL CANCER